Combination therapy with epidermal growth factor and gastrin increases β-cell mass and reverses hyperglycemia in diabetic NOD mice

Diabetes

Volumn 54, Issue 9, 2005, Pages 2596-2601

  Suarez Pinzon, Wilma L ^a   Yan, Yanhua ^b   Power, Robert ^a   Brand, Stephen J ^b   Rabinovitch, Alex ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b Waratah Pharmaceuticals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; GASTRIN; GLUCOSE; INSULIN;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; CELL TRANSFER; DIABETES MELLITUS; FEMALE; HISTOPATHOLOGY; HYPERGLYCEMIA; INSULITIS; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; TREATMENT OUTCOME;

ANIMALS; DIABETES MELLITUS, TYPE 1; DRUG THERAPY, COMBINATION; EPIDERMAL GROWTH FACTOR; FEMALE; GASTRINS; HYPERGLYCEMIA; ISLETS OF LANGERHANS; MICE; MICE, INBRED NOD;

EID: 24144446405     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.54.9.2596     Document Type: Article

References (34)

1. Ryan EA, Lakey JRT, Paty BW, Imes S, Korbutt GS, Bigam D, Rajotte RV, Kneteman NM, Shapiro AMJ: Successful islet transplantation: continued insulin reserve provides long-term glycemic control. Diabetes 51:2148-2157, 2002
2. Rother KI, Harlan DM: Challenges facing islet transplantation for the treatment of type 1 diabetes mellitus. J Clin Invest 114:877-883, 2004
3. Lechner A, Habener JF: Stem/progenitor cells derived from adult tissues: potential for the treatment of diabetes mellitus. Am J Physiol 284:E259-E266, 2003
4. Trucco M: Regeneration of the pancreatic β-cell. J Clin Invest 115:5-12, 2005
5. Green IC, Taylor KW: Effects of pregnancy in the rat on the size and insulin secretory response of the islets of Langerhans. Endocrinology 54:317-325, 1972
6. Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA, Butler PC: β-cell deficit and increased β-cell apoptosis in humans with type 2 diabetes. Diabetes 52:102-110, 2003
7. Bonner-Weir S, Baxter LA, Schuppin GT, Smith FE: A second pathway for regeneration of adult exocrine and endocrine pancreas: a possible recapitulation of embryonic development. Diabetes 42:1715-1720, 1993
8. Vinik A, Pittenger G, Rafaeloff R, Rosenberg L, Duguid WP: Determinants of pancreatic islet cell mass: a balance between neogenesis and senescence/apoptosis. Diabetes Review 4:235-263, 1996
9. Gu D, Sarvetnick N: Epithelial cell proliferation and islet neogenesis in IFN-γ transgenic mice. Development 118:33-46, 1993
10. Sreenan S, Pick AJ, Levisetti M, Baldwin AC, Pugh W, Polonsky KS: Increased β-cell proliferation and reduced mass before diabetes onset in the nonobese diabetic mouse. Diabetes 48:989-996, 1999
11. Maki T, Ichikawa T, Blanco R, Porter J: Long-term abrogation of autoimmune diabetes in nonobese diabetic mice by immunotherapy with anti-lymphocyte serum. Proc Natl Acad Sci U S A 89:3434-3438, 1992
12. Chatenoud L, Thervet E, Primo J, Bach JF: Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice. Proc Natl Acad Sci U S A 91:123-127, 1994
13. Zorina TD, Subbotin VM, Bertera S, Alexander AM, Haluszczak C, Gambrell B, Bottino R, Styche AJ, Trucco M: Recovery of the endogenous beta cell function in the NOD model of autoimmune diabetes. Stem Cells 21:377-388, 2003
14. Kodama S, Kuhtreiber W, Fujimura S, Dale EA, Faustman DL: Islet regeneration during the reversal of autoimmune diabetes in NOD mice. Science 302:1223-1227, 2003
15. Song SY, Gannon M, Washington MK, Scoggins CR, Meszoely M, Goldenring JR, Marino CR, Sandgren EP, Coffey RJ Jr, Wright CV, Leach SD: Expansion of PDX-1-expressing pancreatic epithelium and islet neogenesis in transgenic mice overexpressing transforming growth factor alpha. Gastroenterology 117:1416-1426, 1999
16. Krakowski ML, Kritzik MR, Jones EM, Krachl T, Lee J, Arnush M, Gu D, Mroczkowski B, Sarvetnick N: Transgenic expression of epidermal growth factor and keratinocyte growth factor in beta-cells results in substantial morphological changes. J Endocrinol 162:167-175, 1999
17. Cras-Meneur C, Elghazi L, Czernichow P, Scharfmann R: Epidermal growth factor increases undifferentiated pancreatic embryonic cells in vitro: a balance between proliferation and differentiation. Diabetes 50:1571-1579, 2001
18. Huotari MA, Palgi J, Otonkoski T: Growth factor-mediated proliferation and differentiation of insulin-producing INS-1 and RINm5F cells: identification of betacellulin as a novel β-cell mitogen. Endocrinology 139:1494-1499, 1998
19. Yamamoto K, Miyagawa J, Waguri M, Sasada R, Igarashi K, Li M, Nammo T, Moriwaki M, Imagawa A, Yamagata K, Nakajima H, Namba M, Tochino Y, Hanafusa T, Matsuzawa Y: Recombinant human betacellulin promotes the neogenesis of β-cells and ameliorates glucose intolerance in mice with diabetes induced by selective alloxan perfusion. Diabetes 49:2021-2027, 2000
20. Xu G, Stoffers DA, Habener JF, Bonner-Weir S: Exendin-4 stimulates both beta-cell replication and neogenesis, resulting in increased beta-cell mass and improved glucose tolerance in diabetic rats. Diabetes 48:2270-2276, 1999
21. Tourrel C, Bailbè D, Meile MJ, Kergoat M, Portha B: Glucagon-like peptide-1 and exendin-4 stimulate β-cell neogenesis in streptozotocin- treated newborn rats resulting in persistently improved glucose homeostasis at adult age. Diabetes 50:1562-1570, 2001
22. Rooman I, Lardon J, Bouwens L: Gastrin stimulates β-cell neogenesis and increases islet mass from transdifferentiated but not from normal exocrine pancreatic tissue. Diabetes 51:686-690, 2002
23. Rooman I, Bouwens L: Islet neogenesis in the regeneration model of rat pancreatic duct ligation requires endogenous gastrin action via CCK2 receptors. Diabetologia 45 (Suppl. 2):A26, 2002
24. Brand SJ, Tagerud S, Lambert P, Magil SG, Tartarkiewicz K, Doiron K, Yan Y: Pharmacological treatment of chronic diabetes by stimulating pancreatic β-cell regeneration with systemic co-administration of EGF and gastrin. Pharmacol Toxicol 91:414-420, 2002
25. Rooman I, Bouwens L: Combined gastrin and epidermal growth factor treatment induces islet regeneration and restores normoglycemia in C57B16/J mice treated with alloxan. Diabetologia 47:259-265, 2004
26. Wang TC, Bonner-Weir S, Oates PS, Chulak M, Simon B, Merlino GT, Schmidt EV, Brand SJ: Pancreatic gastrin stimulates islet differentiation of transforming growth factor alpha-induced ductular precursor cells. J Clin Invest 92:1349-1356, 1993
27. Calnan DP, Fagbemi A, Berlanga-Acosta J, Marchbank T, Sizer T, Lakhoo K, Edwards AD, Playford RJ: Potency and stability of C terminal truncated human epidermal growth factor. Gut 47:622-627, 2000
28. Petersen B, Christinsen J, Rehfeld JF: Acid potency and elimination of the 15-leucine gastrin-17 analogue in man. Scand J Gastroenterol 16:437-440, 1981
29. Ogawa N, List JF, Habener JF, Maki T: Cure of overt diabetes in NOD mice by transient treatment with anti-lymphocyte serum and exendin-4. Diabetes 53:1700-1705, 2004
30. Beck PL, Podolsky DK: Growth factors in inflammatory bowel disease. Inflamm Bowel Dis 5:44-60, 1999
31. Wang RN, Rehfeld JF, Nielsen FC, Kloppel G: Expression of gastrin and transforming growth factor-alpha during duct to islet cell differentiation in the pancreas of duct-ligated adult rats. Diabetologia 40:887-893, 1997
32. Miettinen PJ, Huotari M-A, Koivisto T, Ustinov J, Palgi J, Rasilainen S, Lehtonen E, Keski-Oji J, Otonkoski T: Impaired migration and delayed differentiation of pancreatic islet cells in mice lacking EGF-receptors. Development 127:2617-2627, 2000
33. Brand SJ, Fuller PJ: Differential gastrin gene expression in rat gastrointestinal tract and pancreas during neonatal development. J Biol Chem 263:5341-5347, 1988
34. Suarez-Pinzon WL, Lakey JRT, Brand SJ, Rabinovitch A: Combination therapy with epidermal growth factor and gastrin induces neogenesis of human islet β-cells from pancreatic duct cells and an increase in functional β-cell mass. J Clin Endocrinol Metab 90:3401-3409, 2005